Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 16, 2022 at 04:58 am
Share
Euro-Med Laboratories Phil., Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was PHP 786.37 million compared to PHP 794.47 million a year ago. Net income was PHP 27.38 million compared to PHP 29.93 million a year ago. Basic earnings per share from continuing operations was PHP 0.01 compared to PHP 0.01 a year ago. Diluted earnings per share from continuing operations was PHP 0.01 compared to PHP 0.01 a year ago.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 